Atara BiotherapeuticsATRA
13F holders, Q3 2024 (September 30)1holders −4
0new positions
4sold out
$8.14avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Atara Biotherapeutics Inc. (ATRA) in their 13F filings, down 4 from Q2 2024. 0 opened new positions and 4 sold out. The largest holder was EverSource Wealth Advisors, LLC ($285).
- Company
- Atara Biotherapeutics Inc.
- CUSIP
- 046513107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 4 | $1.5M |
All 13F filers, Q2 2024 → Q3 2024: 182,042 shares sold, net −182,042 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| EverSource Wealth Advisors, LLC | 0.00% | No change | 35 | $285 |
"% of holder's portfolio" is ATRA's weight in each manager's 13F, not the share of Atara Biotherapeutics Inc. the manager owns.